Search / Trial NCT02940535

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response
Launched by NAVY GENERAL HOSPITAL, BEIJING · Oct 19, 2016

Download PDF

Apply for Trial

Trial Information

Current as of April 25, 2025

Unknown status

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

Inclusion Criteria:
• At least two of the following three features must be present: i. Advanced maternal age (≥40 years) or any other risk factor for POR (poor ovarian response); ii. A previous POR (≤3 oocytes with a conventional stimulation protocol); iii. An abnormal ovarian reserve test (i.e. AFC \<7 follicles or AMH \<1.1 ng/ml).
Exclusion Criteria:
• Contraindications for IVF/ICSI
• Contraindications for pregnancy
• Primary ovarian insufficiency
• AFC \<3
• PGD/PGS

About Navy General Hospital, Beijing

Navy General Hospital in Beijing is a prominent medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a leading sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, aiming to enhance patient outcomes and contribute to medical knowledge. With a robust infrastructure, a team of experienced researchers, and a commitment to ethical standards, Navy General Hospital fosters collaborations with various stakeholders to ensure the successful execution of clinical trials that address pressing health challenges.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Wei Shang, Dr

Principal Investigator